Brand: ProteoGenix

Namilumab Biosimilar – Anti-CSF2, GM-CSF mAb – Research Grade

PX-TA1259-100UG
Quality Chart

Clonality:: Monoclonal Antibody
Isotype:: IgG1, kappa

$238.00

100ug + 238 loyalty points

Size Size

100ug $238.00
1MG $952.00

First Name This field is required. Last Name This field is required. Email This field is required. Company This field is required. Country This field is required. State This field is required.

In Stock
Wide range of unique reagents
Fast worldwide delivery

Namilumab Biosimilar - Anti-CSF2, GM-CSF mAb binds to Human CSF2/GM-CSF in indirect ELISA Assay

Namilumab Biosimilar - Anti-CSF2, GM-CSF mAb - Research Grade

Product name	Namilumab Biosimilar - Anti-CSF2, GM-CSF mAb - Research Grade
Source	CAS 1206681-39-1
Species	Homo sapiens
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Applications	ELISA,WB
Aliases /Synonyms	Namilumab,MT203,CSF2, GM-CSF,anti-CSF2, GM-CSF
Reference	PX-TA1259
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG1-kappa
Clonality	Monoclonal Antibody

Product name	Namilumab Biosimilar - Anti-CSF2, GM-CSF mAb - Research Grade
Source	CAS 1206681-39-1
Species	Homo sapiens
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Applications	ELISA,WB,,,
Aliases /Synonyms	Namilumab,MT203,CSF2, GM-CSF,anti-CSF2, GM-CSF
Reference	PX-TA1259
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG1-kappa
Clonality	Monoclonal Antibody

General information on Anti-CSF2/GM-CSF[Homo sapiens] (Namilumab) Monoclonal Antibody

Namilumab has beeninvestigated for the treatment of Plaque Psoriasis and Rheumatoid Arthritis.

Namilumab Biosimilar - Anti-CSF2, GM-CSF mAb binds to Human CSF2/GM-CSF in indirect ELISA Assay

Immobilized CSF2 / GM-CSF (in Mammalian), C-His, recombinant protein (cat. No.PX-P5667) at 0.5µg/mL (100µL/well) can bind Namilumab Biosimilar - Anti-CSF2, GM-CSF mAb (cat. No.PX-TA1259) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 34.24M.

There are no reviews yet.

Be the first to review “Namilumab Biosimilar – Anti-CSF2, GM-CSF mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Your rating *

In which application did you use the antibody? *

Did it work in your application? * Yes No

Your review *

Name *

Email *

Namilumab Biosimilar – Anti-CSF2, GM-CSF mAb – Research Grade

Namilumab Biosimilar - Anti-CSF2, GM-CSF mAb - Research Grade

General information on Anti-CSF2/GM-CSF[Homo sapiens] (Namilumab) Monoclonal Antibody

Namilumab Biosimilar - Anti-CSF2, GM-CSF mAb binds to Human CSF2/GM-CSF in indirect ELISA Assay

Related products

Granulocyte-macrophage colony-stimulating factor receptor subunit alpha(CSF2RA)

CD131 recombinant protein

CD116 / CSF2RA, C-His, recombinant protein

CSF2 / GM-CSF (in E.coli), C-His, recombinant protein

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

Namilumab ELISA Kit

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Namilumab Biosimilar – Anti-CSF2, GM-CSF mAb – Research Grade

Specifications Namilumab Biosimilar - Anti-CSF2, GM-CSF mAb - Research Grade

Description

General information on Anti-CSF2/GM-CSF[Homo sapiens] (Namilumab) Monoclonal Antibody

Documents

QC & Validation

Namilumab Biosimilar - Anti-CSF2, GM-CSF mAb binds to Human CSF2/GM-CSF in indirect ELISA Assay

Reviews

Related products

Granulocyte-macrophage colony-stimulating factor receptor subunit alpha(CSF2RA)

CD131 recombinant protein

CD116 / CSF2RA, C-His, recombinant protein

CSF2 / GM-CSF (in E.coli), C-His, recombinant protein

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

Namilumab ELISA Kit

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Namilumab Biosimilar - Anti-CSF2, GM-CSF mAb - Research Grade